Central action of 2-amino- and 2-amino-5-aryltetrahydropyrimidinediones-4,6.
The influence on the central nervous system of five 2-amino- and 2 amino-5-aryltetrahydropyrimidinedione-4,6 derivatives was studied. The most favorable action was exerted by benzylamine-tetrahydropyrimidinedione, which inhibited spontaneous and amphetamine-induced motility most strongly, acted synergistically with hexobarbital, was the only one of the studied group of compound which delayed convulsions induced with pentamethylenetetrazole and amphetamine, and potentiated most strongly the central action of DOPA in mice with inhibited MAO activity. The weakest effects were produced by methylpiperazinephenyl-tetrahydropyrimidinedione.
D000661:Amphetamine; D000698:Analgesia; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D006591:Hexobarbital / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced; D011744:Pyrimidinones / Q000494:pharmacology* / Q000633:toxicity; D012640:Seizures / Q000139:chemically induced; D012890:Sleep / Q000187:drug effects; D013777:Tetrazoles / Q000494:pharmacology
D011744:Pyrimidinones; D013777:Tetrazoles; D004295:Dihydroxyphenylalanine; D006591:Hexobarbital; D000661:Amphetamine